(2016) found that the modulatory effects of PCSK9 GOF genetic variants increased the incidence of T2DM (17) compared with patients in whom FH was caused by the LDLR mutation alone (P<0.05). This evidence concerns the gene PCSK9 and familial hyperaldosteronism.